YAP1 and lung carcinoma: In addition, YAP/TAZ are activated in multiple human tumors including BC, hepatocellular carcinoma (HCC), prostate cancer, and lung cancer,68, 69, 70, 71 which is considered to be indicative of poor prognosis.